MedPath

Computerized Cognitive Training for Schizophrenia in Brazil

Phase 3
Conditions
Schizophrenia
Interventions
Behavioral: Computerized cognitive training
Registration Number
NCT02591498
Lead Sponsor
Universidade Federal do Rio de Janeiro
Brief Summary

The purpose of this study is to investigate the effect of a neuroplasticity-based computerized cognitive training for people with schizophrenia in the Brazilian population.

Detailed Description

Cognitive impairments are important determinants of functional outcome in schizophrenia, which are inadequately treated by antipsychotic medication. Neuroplasticity based computerized cognitive trainings have been emerging for the last two decades and are an attempt to help patients with their cognitive impairments and global functioning.

The aim of this study is to perform a computerized cognitive training to improve attention, concentration, learning, clinical symptoms and quality of life in patients. The investigators are interested in testing the differential efficacy between a specific visual versus auditory computerized cognitive training and explore the biological markers that may be involved in these neuroplasticity based training processes.

The investigators will conduct a 40 hours computerized, adaptable, perception specific, cognitive training program in patients with schizophrenia. Patients will come for 1 hour, daily, and perform a visual or auditory training, or control games for about 2 months. Visual and auditory exercises are chosen to be the equivalent of one another and target cognitive domains such as divided attention, working memory and social cognition. Clinical, cognitive, emotional and biomarker data will be collected before the training, half way through, and after the training, to assess progress in several aspects of their functioning and biology.

The investigators hypothesize visual and auditory trainings will be effective as compared to the control games. They also expect that auditory training to be more efficient compared to the visual training because it targets sensory functions that are mostly impaired in schizophrenia, due to auditory hallucinations patients experience. The investigators also hypothesize that both trainings will improve clinical symptoms and quality of life. On a more exploratory analysis, the investigators expect to identify new biological markers of cognitive neuroplasticity, which they expect will differentiate visual and auditory paths.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • clinical diagnosis of schizophrenia or schizoaffective disorder based on DSM-IV criteria
  • age 18- 60 years
  • Portuguese as primary language (learned before age 12)
  • no major medical or neurological disorder that precludes participation in the study
Exclusion Criteria
  • IQ score <70
  • active substance dependence (DSM-IV criteria)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Video GamesComputerized cognitive trainingAdministration of 40 hours of commercial video games
VisualComputerized cognitive trainingAdministration of 40 hours of visual training exercises
AuditoryComputerized cognitive trainingAdministration of 40 hours of auditory training exercises
Primary Outcome Measures
NameTimeMethod
Global cognition score changethrough study completion, an average of 1 year

The global cognition score is a composite measure from the MATRICS (Measurement And Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery tests

Secondary Outcome Measures
NameTimeMethod
Processing speed score changethrough study completion, an average of 1 year

Processing speed score will be measured using the Motor task from CANTAB (Cambridge Neuropsychological Test Automated Battery) test and the category fluency

Attention score changethrough study completion, an average of 1 year

Attention score will be measured using the Reaction time test and Rapid visual processing CANTAB tests

Working memory score changethrough study completion, an average of 1 year

Working memory will be measured using the Spatial working memory CANTAB test and the digit backward

Verbal memory and learning score changethrough study completion, an average of 1 year

Verbal memory and learning score will be measured using the Hopkins verbal learning test

Visuospatial memory and learning score changethrough study completion, an average of 1 year

Visuospatial memory and learning score will be measured using the brief visuospatial memory test

Reasoning and problem solving score changethrough study completion, an average of 1 year

Reasoning and problem solving score will be measured using the Stockings of Cambridge CANTAB test

Reward task score changethrough study completion, an average of 1 year

Reward task score will be measured using the reward task (adapted from Graham Murray)

Emotional inhibition control score changethrough study completion, an average of 1 year

Emotional inhibition control score will be measured using the Affective go no go CANTAB test

Biological markers from the glutamatergic system changethrough study completion, an average of 1 year

Biological markers from the glutamatergic system will be measured using High profile liquid chromatography

Genes of neuroplasticitythrough study completion, an average of 1 year

Genes of neuroplasticity will be measured using candidate genotyping and Genome wide analysis

Eotaxin 1 changethrough study completion, an average of 1 year

Levels of eotaxin 1 will be measured using ELISA kit

Prepulse inhibition changethrough study completion, an average of 1 year

Prepulse inhibition will be measured via eye muscle reaction to sound

Eye-tracking changethrough study completion, an average of 1 year

Eye-tracking will be measured via an infrared camera while patients do cognitive tests

Electroencephalogram (EEG) changethrough study completion, an average of 1 year

EEG will be measured with electrodes on the surface of the skull while patients do cognitive tests

motivation scores changethrough study completion, an average of 1 year

Motivation scores will be measured with an interview and the Behavior Inhibition/Activation Scale questionnaire

Depression score changethrough study completion, an average of 1 year

Depression score will be measured using the Hamilton - Depression questionnaire

Anxiety score changethrough study completion, an average of 1 year

Depression score will be measured using the Hamilton - Anxiety questionnaire

Mood scores changethrough study completion, an average of 1 year

mood scores will be measured using the Visual analogue scale (Norris 1971)

Positive and negative syndrome scale score changethrough study completion, an average of 1 year

Clinical score will be measured using the Positive and Negative Syndrome Scale for Schizophrenia

Quality of Life changethrough study completion, an average of 1 year

Quality of life will be measured using the World Health Organization of quality of life

Trial Locations

Locations (1)

Federal University of Rio de Janeiro

🇧🇷

Rio de Janeiro, RJ, Brazil

© Copyright 2025. All Rights Reserved by MedPath